Design Sofosbuvir / velpatasvir

for 12 weeks in liver transplant recipients with genotype 14 Agarwal K J Hepatol 2018696037 SOFVEL 400100 mg 1 tablet QD Liver transplant recipients Recurrent HCV infection after transplantation

Embed this Presentation

Download Notice

Download Presentation The PPT/PDF document "Design Sofosbuvir / velpatasvir" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.